Drug application
PYTEST (UREA, C-14)
Drugs@FDA NDA 020617 · AVENT
Key facts
| Drug name | PYTEST |
|---|---|
| Active ingredients | UREA, C-14 |
| Application type | NDA |
| Application number | 020617 |
| Company | AVENT |
| Dosage forms | CAPSULE, ORAL |
| Strength | 1uCi |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | May 9, 1997 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.